Action Plan A1 ACTION GROUP Prescription and adherence to treatment

Transcription

1 Action Plan A1 ACTION GROUP Prescription and adherence to treatment

2 What is the Action Plan A1 AG about? Objectives 1. Improve patients' adherence 2. Empowerment 3. Contribute to the improvement of adherence in the health care system 4. Contribute to the research and methodology 5. Foster communication Activities Develop early warning systems, IT platforms, electronic tools, alerting systems, assessment tools, pharmaceutical care services, device to monitor drug compliance, integrated group programme to combine medical advice, adherence support services for community pharmacists. Implement exercise training, consistent and reliable use of the «Teachback» approach, patient access to clinical information. Develop a web based social network, physically and intellectually stimulating social activities. Design specific content for informative campaigns. Carry out group therapeutic education and psycological and health counselling. Develop ICT solutions, a content sharing platform, cost monitoring programmes, electonic prescription tools. Design a specific informative campaigns. Implement pharmaco-vigilance programmes and software, best practices and guidelines. Use of the SPARRA risk prediction algorithm, train health professionals. Develop research on therapies and strategies for poly-medicated patients; an algorithm to identify indicators of adherence. Establish public-private approaches. Evaluate different strategies cost-effectiveness. Perform observational study, cost analysis, health technology assessment of innovative life style model. Use the Scottish patients algorithm Design database and specific software to support IT platform. Create an EU database of clinical trials for older people.share pharmaceutical care record across primary and secondary care.

3 What is the Action Plan A1 AG about? Objectives 1. Improve patients' adherence 2. Empowerment 3. Contribute to the improvement of adherence in the health care system 4. Contribute to the research and methodology 5. Foster communication Deliverables Sms alert, warning signals, sensor prototype, software programmes, lifestyle intervention plans, tele-monitoring electonic device tools, friendly packaging. «Let me decide» programme for end of life care, Expert Patient programme, public lectures, round table discussions, patient personal health folder, health literacy tool for self-management, combined cultural and physical fitness, PhD programme on ageing for health professionals. Medicine reconciliation,reshaping care, electronic prescription, poly-pharmacy demonstrator pilots, roll out of emergency care and chronic medication services, revisiting of national contract for community pharmacists and a Scottish GP contract, advanced care plans for residents in long term care facilities, training programmes for involved professionals, ICT based programs for remote monitoring of health status, lifestyles and adherence, ICT and multi-disciplinar programmes for chronic diseases. Monitoring adherence through databases and observatories, algorithm to identify risk factors for non-adherence and screening tools, market research in renal cancer to understand causes of non- adherence, reproducible model for patient centered care and model to improve lifestyle in type 2 diabetes care, costeffectiveness and HTA analysis, new guidelines for clinical trials in older people, assessment tools for poor adherence in polypharmacy, services for pharmacists to deliver support, novel methods for the stratification of the risk-population. European Network supporting clinical trials, web application about adherence levels, web-based social and stakeholder network, ICT and portal communication.

4 What is the Action Plan A1 AG about? Governance Principles: Openness and partnership common willingness of all partners to cooperate with other relevant partners. Coordination participation of a representative(s) in the coordination meetings of the Action Group Reporting regular reporting from the Action Group's meetings, progress of actions and deliverables to be made public Evaluation outcome of actions to be evaluated, and results made public Role & responsibilities of Partners are: Implement the agreed Action Plan to the agreed standards and deadlines Ensure the effective preparation and delivery of all WG products Evaluate of WG performance and reporting on progress

5 AIFA Consortium: step-wise approach Steps Strategies Partners Time frame First Monitoring / Observational data 1)Monitoring adherence through the utilization of observatories and databases. Collecting all prescription data, data regarding drugs dispensed by pharmacies, monitoring further prescriptions of the same patient and disease, admissions of these patients to hospital and diagnosis, registration of negative clinical outcome Second Development and implementation of interventions Third Data analysis 2)Identification of causes of poor adherence- establish risk definitions to tailor interventions 3) Evaluation of adherence-patients clinical outcome correlation 1) Implementation of Interventions addressed to improve poor adherence a) Empower patients and their careers b) Development and implementation of education programs c) Implementation of determinant number of text message reminders,gesi Health KIT devices or other specific device d) Implementation of older persons friendly packaging, formulations or containers (with or without reminders) 2) Follow-up of implemented strategies a) identification of indicators b) progress monitoring c) identification of key gaps and difficulties IRCCS S. Raffaele Pisana Universities :Florence, Groningen, UCSC, Bologna, Napoli. GESI- Rome Merk Serono NCSR-Greece Philips Research Eindhoven EGA EPF GSK ASL Brescia Pfitzer Italy GIRP Bruxelles Belgium )Data analysis, results presentation and final report

6 NHS Scotland Third Sector organization Steps Strategies Partners Time frame First Monitoring / Observational data 1) Review of pharmaceutical care in the community e- health strategy-electronic prescribing captured by all clinicians in primary and secondary care will allow for accurate picture of medications patients are taking. This will allow the monitoring not only of adherence but of safe and effective prescribing. Examples include electronic prescribing and HEPMA 2)Identification of causes of poor prescribing - establish risk definitions to tailor interventions. Guidance on dealing with appropriate prescribing and initial outcome data from Boards addressing Polypharmacy and value of risk of admissions data to inform which patient groups to target. Starting in Second Development and implementation of interventions Third Data analysis 1) Implementation of Interventions addressed to improve poor adherence a) Implement use of a health literacy tools b) ICT and portal communication to maximize clinical communication b) Tools that patients can use to help them manage their medication c) Toolkit to support the sharing of good practice and the promotion of literacy sensitivity d) Collaboration in working on polypharmacy and pharmaceutical care 2) Follow-up of implemented strategies 1)Data analysis, results presentation and final report Starting in

7 Partners members of AG A1 AIFA Consortium NHS Scotland GSK CIRFF, University of Naples/Campania Region APSS University Coimbra Department of Health and Consumer Affairs of the Basque Government Perugia University Education, Health and Society Foundation Murcia Veneto Region Medical university of Warsaw UCC Cork General Council of pharmacists ParkinsonNet (Radboud University Nijmegen Medical Centre) ParkinsonNet (Radboud University Nijmegen Medical Centre) GIRP-European Association of Pharmaceutical Full-line Wholesalers, Brussels, Belgium